This caught my eye in the PR. "Across the combined study arms, the weekly rates of nausea or vomiting did not exceed 5% at any point after the third week of treatment."
Estimated WORST-case weekly chance of vom. in 120mg arm > week 3 is 2.9% (1/34 weeks you will vomit). pic.twitter.com/k6x7RM7JhT